Poolbeg Pharma PLC (AIM:POLB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
8.50
-0.20 (-2.30%)
Aug 14, 2026, 4:35 PM GMT

Poolbeg Pharma Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-6.33-6.33-6.57-4.69-4.99-3.11
Net Income
-5.7-5.7-5.79-3.93-4.69-3.11
Earnings Per Share
-0.01-0.01-0.01-0.01-0.01-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
7.717.717.8212.1716.1920.95
Net Cash Growth
-22.57%-1.42%-35.72%-24.84%-22.70%-
Net Cash Per Share
0.010.010.020.020.030.07
Cash & Investments
7.717.717.8212.1716.1920.95

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.76-4.76-4.65-4.38-4.37-2.86
Free Cash Flow
-4.76-4.76-4.65-4.38-4.37-2.86
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.